AHA: Apixaban Beneficial for Patients With Subclinical A-Fib
Risk for stroke or systemic embolism lower with apixaban versus aspirin for patients with subclinical a-fib
AHA: No Real Benefit Seen for Liberal Transfusion Strategy in AMI, Anemia
Liberal transfusion strategy does not significantly reduce the risk for recurrent myocardial infarction or death
AHA: Semaglutide Cuts Risk for CVD Events in Patients Without Diabetes
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Gender Life Expectancy Gap Increased From 2010 to 2021
Leading contributors to widening gender life expectancy gap from 2019 to 2021 included COVID-19, unintentional injuries
ACR: Incidence of Atrioventricular Block Increased With High Levels of Anti-SSA/Ro Antibodies
Incidence of atrioventricular block increased with higher antibody levels, reaching 7.7 percent in top quartile of anti-60 kD SSA-Ro
AHA: Daily Marijuana Use Linked to Incident Heart Failure
And, cannabis use disorder linked to increased odds of major adverse cardiac and cerebrovascular events
AHA: PREVENT Risk Calculator Estimates Risk for Cardiovascular Disease
PREVENT equations developed and validated in adults aged 30 to 79 years without known CVD and included eGFR as a predictor
Earlier Onset of A-Fib Linked to Risk of Developing All-Cause Dementia
Younger age at a-fib onset linked to increased risks of all-cause and vascular dementia, Alzheimer disease
AHA: Depression, Anxiety Linked to CVD Risk Factors, MACE
Composite measure of perceived stress associated with atherosclerotic and global cardiovascular disease
AHA: High Cardiovascular Health Linked to Lower Phenotypic Age
Lower phenotypic age, phenotypic age acceleration seen in association with being in highest versus lowest tertile of 'Life's Essential 8'
